These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 17967307
1. Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Yoon SM, Kim DY, Kim TH, Jung KH, Chang HJ, Koom WS, Lim SB, Choi HS, Jeong SY, Park JG. Int J Radiat Oncol Biol Phys; 2007 Nov 15; 69(4):1167-72. PubMed ID: 17967307 [Abstract] [Full Text] [Related]
2. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer. Park YA, Sohn SK, Seong J, Baik SH, Lee KY, Kim NK, Cho CW. J Surg Oncol; 2006 Feb 01; 93(2):145-50. PubMed ID: 16425302 [Abstract] [Full Text] [Related]
8. The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer. Perez RO, São Julião GP, Habr-Gama A, Kiss D, Proscurshim I, Campos FG, Gama-Rodrigues JJ, Cecconello I. Dis Colon Rectum; 2009 Jun 01; 52(6):1137-43. PubMed ID: 19581858 [Abstract] [Full Text] [Related]
9. The role of fibrinogen as a predictor in preoperative chemoradiation for rectal cancer. Lee JH, Hyun JH, Kim DY, Yoo BC, Park JW, Kim SY, Chang HJ, Kim BC, Kim TH, Oh JH, Sohn DK. Ann Surg Oncol; 2015 Jan 01; 22(1):209-15. PubMed ID: 25384698 [Abstract] [Full Text] [Related]
10. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Vecchio FM, Valentini V, Minsky BD, Padula GD, Venkatraman ES, Balducci M, Miccichè F, Ricci R, Morganti AG, Gambacorta MA, Maurizi F, Coco C. Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):752-60. PubMed ID: 15936556 [Abstract] [Full Text] [Related]
13. Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. Kim YH, Kim DY, Kim TH, Jung KH, Chang HJ, Jeong SY, Sohn DK, Choi HS, Ahn JB, Kim DH, Lim SB, Lee JS, Park JG. Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):761-8. PubMed ID: 15936557 [Abstract] [Full Text] [Related]
16. Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer. Min BS, Choi YJ, Pyo HR, Kim H, Seong J, Chung HC, Rha SY, Kim NK. Arch Surg; 2008 Nov 01; 143(11):1091-7; discussion 1097. PubMed ID: 19015468 [Abstract] [Full Text] [Related]
17. Absence of cyclooxygenase-2 protein expression is a predictor of tumor regression in rectal cancer treated with preoperative short-term chemoradiotherapy. Kobayashi H, Hashiguchi Y, Ueno H, Shinto E, Kajiwara Y, Mochizuki H. Dis Colon Rectum; 2007 Sep 01; 50(9):1354-62. PubMed ID: 17308999 [Abstract] [Full Text] [Related]
18. Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer? Kim DW, Kim DY, Kim TH, Jung KH, Chang HJ, Sohn DK, Lim SB, Choi HS, Jeong SY, Park JG. Cancer; 2006 Apr 15; 106(8):1694-700. PubMed ID: 16532432 [Abstract] [Full Text] [Related]
19. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer. Suárez J, Vera R, Balén E, Gómez M, Arias F, Lera JM, Herrera J, Zazpe C. Colorectal Dis; 2008 Jul 15; 10(6):563-8. PubMed ID: 18070184 [Abstract] [Full Text] [Related]
20. Prognostic value of pretreatment level of carcinoembryonic antigen on tumour downstaging and early occurring metastasis in locally advanced rectal cancer following neoadjuvant radiotherapy (30 Gy in 10 fractions). Wang L, Zhong XG, Peng YF, Li ZW, Gu J. Colorectal Dis; 2014 Jan 15; 16(1):33-9. PubMed ID: 23848511 [Abstract] [Full Text] [Related] Page: [Next] [New Search]